Abstract:
Health care has substantial market size and growth and is considered a high priority by governments around the world. Global health care spending accounts for 10.2 percent of GDP through 2023 [Deloitte, 2020 Global Health Care Outlook] and is expected to rise at a CAGR of over 5 percent in the next 5 years. The commercialization of biomedical technology is high-risk but high-value that requires multiple knowledge domains, substantial financing, and user adoption. This creates a serious challenge in translating promising discoveries to benefit the public.
As such, the National Tsing Hua University (NTHU) is poised to provide to strengthen the biotech ecosystem to quicken the pace for translation and adoption of biomedical technology. NTHU will also provider thought leadership and to develop implementation ideas to value-add biomedical technologies throughout the translation continuum, thus augmenting the competitiveness of Taiwan as an international center for health care industry. We will promote Taiwan as an international innovation center for biotech translation.」
NTHU has more than 30 year solid relationship with NSRRC since its establishment in 1986. Nowaday among all the 400 PI users who applied the NSRRC beam time, about 20 % of granted research projects were proposed by NTHU professors.Two NSRRC beamlines were collaborative operated by NTHU, the TLS 07, and TLS B20B in the past. NTHU professors use the NSRRC facilities including protein crystallography beamline, X-ray absorption spectroscopy, X-ray imaging, X-ray diffraction, thin film scattering, small angle X-ray scattering (SAXS) in TLS and TPS and Spring-8 (Japan). In addition, the neutron facility operated by NSRRC in ANSTO(Australia) has been heavily involved by NTHU users as well. Beside most of research cooperations in material science, biomedicine related fields are also very vibrant in many cutting-edge aspects. How to translate top-notched research outcomes into commercial products for health care industry has been becoming as an important question in many countries.
Keywords - Translational Medicine, Social Impact, Biomedical Technology, Value Chain, Healthcare.